Purchase Obligation Definition & Meaning | Financial Term | CSIMarket
CSI Market
Sign In | Register

Glossary

Purchase Obligation

Financial Term

Purchase obligation is an agreement between two parties, usually a buyer and a supplier, whereby the buyer is obligated to purchase a specific quantity of goods or services from the supplier at a predetermined time in the future. Purchase obligations are often used in financial industries to help companies manage their supply chain and ensure a reliable source of goods or services.

In finance, purchase obligations are often used in the context of derivatives contracts, such as options and futures. For example, a futures contract is a type of purchase obligation whereby two parties agree to exchange a specific asset, such as commodities, at a predetermined price and time in the future. These agreements are often used by investors and traders to hedge against price fluctuations and manage their risk exposure.

Purchase obligations can also be used in the context of purchase agreements between companies. In this case, a company may sign a purchase agreement with a supplier to ensure a reliable source of raw materials or components. This type of agreement can be beneficial for both parties as it helps to ensure a stable supply of goods, and may also result in cost savings through bulk purchasing or long-term contracting.

In summary, purchase obligations are a tool used in the financial industry to manage supply chain risk and ensure a reliable source of goods or services. They are often used in the context of derivatives contracts and purchase agreements between companies.


More Glossary Terms Beginning with P
  • Paediatric Exclusivity
    means, in the US, a six-month period of exclusivity to market a drug which is awarded by the FDA in return for certain paediatric clinical studies using that drug. This six-month period runs from the date of relevant patent expiry.
    Health Care Term Letter: P
  • Paid Development Method
    An actuarial method to estimate ultimate losses for a given cohort of claims such as an accident year/product line component. If the paid-to-date losses are then subtracted from the estimated ultimate losses, the result is an indication of the unpaid losses. The basic premise of the method is that cumulative paid losses for a given cohort of claims will grow in a stable, predictable pattern from y
    Insurance Term Letter: P
  • Panelboards
    Oriented strand board, particleboard, medium density fibreboard and plywood. Operating Statistics
    Manufacturing Term Letter: P
  • Partial Remission PR
    A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.
    Health Care Term Letter: P
  • Particleboard
    A panelboard produced by chemically bonding clean sawdust, small wood particles and recycled wood fibre under heat and pressure. Forestry & Wood Products Industry Operating Statistics
    Manufacturing Term Letter: P
  • Particulate Matter
    Total suspended particulate. A measure of the solid particles (wood, process dust and smoke) found in air emissions.
    Manufacturing Term Letter: P
  • Particulates
    Tiny particles of a substance.
    Manufacturing Term Letter: P
  • Passenger Load Factor
    Represents the total number of seats sold as a percentage of total seat capacity on all sectors flown. Airline Industry
    Transportation Term Letter: P
  • Passenger Mile Yield
    The amount of passenger revenue earned per revenue passenger mile during a reporting period Airline Industry
    Transportation Term Letter: P
  • Passenger revenue yield per Mile Average Yield per RPM
    Represents the average scheduled passenger fare revenue for each revenue passenger mile (RPM), or each mile a scheduled revenue passenger is flown. Airline Industry
    Transportation Term Letter: P
  • Passive Immunotherapy
    Immunologically active material transferred into the patient as a passive recipient. Monoclonal antibodies are considered Passive Immunotherapy since antibodies are generated outside the body and given to the patient
    Health Care Term Letter: P
  • Patent Term Extension
    means an extension of up to five years in the term of a US patent relating to a drug which compensates for delays in marketing resulting from the need to obtain FDA approval.
    Health Care Term Letter: P